Last-minute shoppers feel the love in Target’s greeting card aisle
TAMPA, Fla. — Happy Valentine’s Day!
The greeting card department at this Tampa, Fla.-area SuperTarget is prominently located near the store entrance, which contributed to the throng of last-minute love-birds who were drawn to the card assortment upon realizing it was late Sunday afternoon and they had yet to purchase a card to express their emotions.
In SEC filing, A&P reports resignation of CFO
MONTVALE, N.J. — Bankrupt grocer A&P reported in a recent filing with the Securities and Exchange Commission that Brenda Galgano, SVP, CFO and treasurer, will resign, effective March 27.
According to the filing, Galgano gave her notice on Feb. 10. No additional details on her departure were disclosed.
As previously reported by Drug Store News, the grocer elected Greg Rayburn to its board of directors, following the resignation of Jens-Jürgen Böckel. Additional executive changes were announced during A&P’s third-quarter earnings release last month.
Walgreens expands access to shingles vaccine
DEERFIELD, Ill. — With shingles vaccines widely reported to be in short supply from some healthcare providers, Walgreens on Monday announced the expansion of its availability of Zostavax — a one-time vaccine that can reduce the risk of shingles in individuals ages 60 years and older — and now is offering shingles vaccinations daily at more than 2,000 Walgreens stores and Take Care Clinics.
"Our pharmacists, Take Care Clinic nurse practitioners and other healthcare professionals have been instrumental in creating a growing awareness of the benefits of the shingles vaccine, and in educating the public on why it’s particularly important for those over 60 [years]," stated Kermit Crawford, Walgreens president of pharmacy services. "Walgreens’ network of more than 26,000 certified immunizers has demonstrated our unique capabilities to provide a wide range of [the Centers for Disease Control and Prevention]-recommended vaccinations when it’s most convenient for our patients."
The CDC recommends Zostavax for those older than 60 years of age to help reduce the risk of shingles. The agency estimated nearly one-third of Americans will develop shingles at some point, with more than 1 million people in the United States developing the painful skin rash or nerve disease each year. Shingles can affect anyone who has had chickenpox; however, it is most common in people ages 50 years and older.